Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
India · Delayed Price · Currency is INR 109.48
-1.67 (-1.50%)
At close: Oct 1, 2026
NSE:GAUDIUMIVF Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,060 | 1,044 | 707.24 | 478.9 | 442.37 | 365.2 |
Other Revenue | - | - | - | - | 0.19 | - |
| 1,060 | 1,044 | 707.24 | 478.9 | 442.55 | 365.2 | |
Revenue Growth | 45.91% | 47.55% | 47.68% | 8.21% | 21.18% | 491.39% |
Cost of Revenue | 515.3 | 506.5 | 284.14 | 164.51 | 144.71 | 91.54 |
Gross Profit | 544.47 | 537.07 | 423.1 | 314.39 | 297.84 | 273.65 |
Selling, General & Admin | - | 25.95 | 25.02 | 80.14 | 54.13 | 47.37 |
Other Operating Expenses | 194.72 | 134.08 | 111.77 | 41.5 | 42.88 | 89.36 |
Operating Expenses | 221.34 | 185.51 | 157.26 | 143.23 | 111.34 | 146.44 |
Operating Income | 323.13 | 351.56 | 265.84 | 171.16 | 186.5 | 127.21 |
Interest Expense | -33.7 | -34.86 | -13.91 | -7.48 | -3.42 | -4.51 |
Interest & Investment Income | 10.22 | 4.8 | 2.29 | 0.13 | 0.05 | 0.04 |
Earnings From Equity Investments | - | - | - | - | - | -0.02 |
Other Non Operating Income (Expenses) | 6.32 | -0.06 | 0 | 2.5 | - | -0 |
EBT Excluding Unusual Items | 305.98 | 321.45 | 254.22 | 166.32 | 183.12 | 122.72 |
Gain (Loss) on Sale of Assets | - | 0.32 | - | - | - | - |
Other Unusual Items | - | 0.19 | 0.05 | - | - | - |
Pretax Income | 305.98 | 321.96 | 254.27 | 166.32 | 183.12 | 122.72 |
Income Tax Expense | 74.09 | 77.07 | 62.49 | 63.15 | 47.87 | 31.71 |
Earnings From Continuing Operations | 231.88 | 244.89 | 191.79 | 103.17 | 135.25 | 91.01 |
Earnings From Discontinued Operations | -0.28 | -0.28 | -0.05 | - | - | - |
Net Income | 231.61 | 244.61 | 191.74 | 103.17 | 135.25 | 91.01 |
Net Income to Common | 231.61 | 244.61 | 191.74 | 103.17 | 135.25 | 91.01 |
Net Income Growth | 27.74% | 27.58% | 85.85% | -23.72% | 48.61% | 10169.96% |
Shares Outstanding (Basic) | 65 | 62 | 61 | 61 | 61 | 61 |
Shares Outstanding (Diluted) | 65 | 62 | 61 | 61 | 61 | 61 |
Shares Change | 5.57% | 1.55% | - | - | - | - |
EPS (Basic) | 3.57 | 3.92 | 3.12 | 1.68 | 2.20 | 1.48 |
EPS (Diluted) | 3.57 | 3.92 | 3.12 | 1.68 | 2.20 | 1.48 |
EPS Growth | 21.00% | 25.64% | 85.71% | -23.64% | 48.41% | 10195.06% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 51.11 | -1.61 | 6.54 | 85.97 | - |
Free Cash Flow Per Share | - | 0.82 | -0.03 | 0.11 | 1.40 | - |
Gross Margin | 51.38% | 51.47% | 59.82% | 65.65% | 67.30% | 74.93% |
Operating Margin | 30.49% | 33.69% | 37.59% | 35.74% | 42.14% | 34.83% |
Profit Margin | 21.85% | 23.44% | 27.11% | 21.54% | 30.56% | 24.92% |
Free Cash Flow Margin | - | 4.90% | -0.23% | 1.37% | 19.43% | - |
EBITDA | 350.6 | 374.57 | 283.37 | 190.26 | 200.36 | 136.93 |
EBITDA Margin | 33.08% | 35.89% | 40.07% | 39.73% | 45.27% | 37.49% |
D&A For EBITDA | 27.47 | 23.01 | 17.53 | 19.09 | 13.86 | 9.72 |
EBIT | 323.13 | 351.56 | 265.84 | 171.16 | 186.5 | 127.21 |
EBIT Margin | 30.49% | 33.69% | 37.59% | 35.74% | 42.14% | 34.83% |
Effective Tax Rate | 24.22% | 23.94% | 24.57% | 37.97% | 26.14% | 25.84% |
Revenue as Reported | 1,076 | 1,049 | 709.58 | 481.53 | 442.6 | 365.24 |
Advertising Expenses | - | - | - | 57.01 | 32.97 | 42.82 |